drugset / Trial / NCT06491394
Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis Rats
RandomizedParallel-groupTriple-blindPrevention
Summary
This study focuses on detecting the possible beneficial effect of Lactoferrin (Lf) administration on the kidney and the heart of glycerol-induced rhabdomyolysis (RM) in rats and its relation to ferroptosis and AMPK/Nrf2/ HO-1 signalling pathway. The main questions it aims to answer are: 1. Is Lf administration 30 min. before or after RM induction in rats beneficial to kidneys and heart? 2. When administered to glycerol-induced rats, does Lf act by upregulating the AMPK/Nrf2/ HO-1 signalling pathway and inhibiting ferroptosis?
Timeline
- Start
- 2024-11-01
- Primary completion
- 2025-03-01
- Completion
- 2025-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lactoferrin | Protein / enzyme biologic | 1000 mg/kg | Oral |
| Comparator | Glycerin | Other / unclassified | 10 ml | Intramuscular |